TD Cowen analyst Charles Rhyee downgraded DarioHealth (DRIO) to Hold from Buy with a price target of $1, down from $2.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.